David Sermer
Impact in
-
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
-
- Lymphoma Diagnosis and Treatment
Papers in
- Oncology 11
- CAR-T cell therapy research 8
-
- Lymphoma Diagnosis and Treatment 8
- Co-authors
- Renier J. Brentjens (1 shared paper)Anas Younes (5 shared papers)Ari Melnick (1 shared paper)Hans‐Guido Wendel (1 shared paper)Laura Pasqualucci (1 shared paper)Kenneth Getz (1 shared paper)Robert E. Martell (1 shared paper)Kenneth I. Kaitin (1 shared paper)
- Journals
- Blood (8 papers)Hematological Oncology (3 papers)Journal of Clinical Oncology (2 papers)The Oncologist (2 papers)Nature Reviews Clinical Oncology (1 paper)
- Partner nations
- United StatesSouth KoreaUnited Kingdom
In The Last Decade
David Sermer
21 papers receiving 379 citations
Peers
Comparison fields: 5 of 55
- Oncology 219
- Pathology and Forensic Medicine 106
- Genetics 54
- Immunology 93
- Hematology 30
Countries citing papers authored by David Sermer
This map shows the geographic impact of David Sermer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Sermer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Sermer more than expected).
Fields of papers citing papers by David Sermer
This network shows the impact of papers produced by David Sermer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Sermer. The network helps show where David Sermer may publish in the future.
Co-authors
The 25 scholars most cited alongside David Sermer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 138 | |
| 2 | 2019 | 94 | |
| 3 | 2012 | 30 | |
| 4 | 2022 | 17 | |
| 5 | 2023 | 14 | |
| 6 | 2023 | 14 | |
| 7 | 2014 | 12 | |
| 8 | 2023 | 12 | |
| 9 | 2022 | 10 | |
| 10 | 2024 | 9 | |
| 11 | 2022 | 8 | |
| 12 | 2007 | 6 | |
| 13 | 2024 | 4 | |
| 14 | 2020 | 4 | |
| 15 | 2022 | 3 | |
| 16 | 2024 | 3 | |
| 17 | 2022 | 3 | |
| 18 | 2024 | 2 | |
| 19 | 2016 | 2 | |
| 20 | 2019 | 1 |
About David Sermer
David Sermer is a scholar working on Oncology, Pathology and Forensic Medicine, Molecular Biology, Genetics and Immunology, having authored 22 papers that have together received 387 indexed citations. Recurring topics across this work include CAR-T cell therapy research (8 papers), Lymphoma Diagnosis and Treatment (8 papers), Chronic Lymphocytic Leukemia Research (6 papers), Protein Degradation and Inhibitors (4 papers), Biosimilars and Bioanalytical Methods (3 papers), Histone Deacetylase Inhibitors Research (3 papers), Chronic Myeloid Leukemia Treatments (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). The work is most often cited by research in Oncology (219 citations), Pathology and Forensic Medicine (106 citations), Genetics (54 citations), Immunology (93 citations) and Hematology (30 citations). David Sermer has collaborated with scholars based in United States, South Korea and United Kingdom. Frequent co-authors include Renier J. Brentjens, Anas Younes, Ari Melnick, Hans‐Guido Wendel, Laura Pasqualucci, Kenneth Getz, Robert E. Martell, Kenneth I. Kaitin, Jeremy S. Abramson and Steven P. Treon. Their work appears in journals such as Blood, Hematological Oncology, Journal of Clinical Oncology, The Oncologist and Nature Reviews Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.